Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Orticumab (MLDL1278A) is an antibody that specifically targets and inhibits oxidized or malondialdehyde-modified low-density lipoprotein (oxLDL), playing a role in the modulation of autoimmune responses against oxLDL and showing potential in improving atherosclerosis in animal models. Additionally, Orticumab has been researched for its effectiveness in the improvement of psoriasis [1] [2].
説明 | Orticumab (MLDL1278A) is an antibody that specifically targets and inhibits oxidized or malondialdehyde-modified low-density lipoprotein (oxLDL), playing a role in the modulation of autoimmune responses against oxLDL and showing potential in improving atherosclerosis in animal models. Additionally, Orticumab has been researched for its effectiveness in the improvement of psoriasis [1] [2]. |
分子量 | N/A |
CAS No. | 1314241-10-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Orticumab 1314241-10-5 Inhibitor inhibitor inhibit